Clinical trials involving KLH. Details such as study status, design and investigators are available by link to outside sites.Donor Lymphocyte Infusion for Myeloma
Conditions: Myeloma
Sponsors: M.D. Anderson Cancer Center
Phase II
July 30, 2010 Cancer - Myeloma Conditions: Sarcoma
Sponsors: MabVax Therapeutics, Inc.
Phase II
June 9, 2010 Cancer - Sarcoma Safety of IFNa Kinoid in Systemic Lupus Erythematosus
Conditions: Systemic Lupus Erythematosus
Sponsors: Neovacs
Phase I, II
January 27, 2010 Immune Disease - Autoimmune, Lupus Erythematosus Phase I Rindopepimut After Conventional Radiation in Children w/ Diffuse Intrinsic Pontine Gliomas
Conditions: Brain Cancer, Brain Stem Tumors, Pontine Tumors
Sponsors: Stanford University
Phase I
January 27, 2010 Cancer - Brain & CNS, Pediatric Conditions: Rheumatoid Arthritis
Sponsors: Neovacs
Phase II
December 28, 2009 Arthritis, Immune Disease - Autoimmune Dendritic Cells(DC)-Based Id Vaccination in Stage-I Myeloma
Conditions: Multiple Myeloma, Plasmocytoma
Sponsors: University Hospital Carl Gustav Carus
Phase I
October 1, 2009 Cancer - Myeloma, Cancer - Other, Cancer - Tissue Conditions: Neuroblastoma
Sponsors: Memorial Sloan-Kettering Cancer Center
Phase I
May 29, 2009 Cancer - Brain & CNS Immunoglobulin and QS-21 in Patients With Follicular Lymphomas
Conditions: Lymphoma
Sponsors: National Cancer Institute (NCI)
Phase I
April 8, 2009 Cancer - Lymphoma Conditions: Fallopian Tube Cancer, Ovarian Cancer, Primary Peritoneal Cavity Cancer
Sponsors: Gynecologic Oncology Group, National Cancer Institute (NCI)
Phase II
March 5, 2009 Cancer - Female Reproductive, Cancer - Peritoneal Safety and Immunogenicity of a TNFa Kinoid in Patients With Crohn's Disease
Conditions: Crohn's Disease
Sponsors: Neovacs
Phase I, II
December 12, 2008 Crohn's Disease, Inflammatory Disease